Anthony Doyle - Chief Financial Officer at Biocryst Pharmaceuticals Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
BCRX on Nasdaq
All Insider Reports
All Insider Reports

Anthony Doyle - trading volume in the past year for Biocryst Pharmaceuticals Inc

Holdings reported by Anthony Doyle for Biocryst Pharmaceuticals Inc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 267K $1.49M $5.57 May 14, 2024 Direct
Emp. Stock Option (Right to Buy) 159K Dec 14, 2023 Direct Common Stock

Transactions reported by Anthony Doyle for Biocryst Pharmaceuticals Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.